A Multiple-Dose Study of MK-1006 (MK-1006-004)(TERMINATED)

计划入组 112 人 · 首次发布于 2008 年 9 月 25 日

MK-1006 Single Dose Study in Japanese Type 2 Diabetes Patients (MK-1006-005)

计划入组 24 人 · 首次发布于 2008 年 11 月 14 日

A Study of the Pharmacokinetics of Two Formulations of MK-1006 (MK-1006-010 AM1)(COMPLETED)

计划入组 12 人 · 首次发布于 2009 年 9 月 18 日

TI-1006

MSP-1006

NOVA-1006

Klinikum am Weissenhof

Germany

INSTITUT D'ANESTHESIOLOGIE DES AM

France

Berufsgenossenschaftliche Unfallklinik Frankfurt am Main

Germany

Arcadia Medicine Receives FDA Clearance for Novel Non-Racemic MDMA Compound AM-1002

Arcadia Medicine Receives FDA Approval for Clinical Trials of Safer MDMA Formulation AM-1002

Organogenesis PuraPly AM Shows Significant Efficacy in Diabetic Foot Ulcer Trial